Biogen cuts the price tag on its Alzheimer's drug in half
Biogen is slashing the price of its Alzheimer's treatment in half months after it debuted to widespread criticism for an initial cost that could reach $56,000 annually.
Dec 20, 2021
0
5
Biogen is slashing the price of its Alzheimer's treatment in half months after it debuted to widespread criticism for an initial cost that could reach $56,000 annually.
Dec 20, 2021
0
5
(HealthDay)—Nearly 13 million U.S. adults a year skip or delay filling needed prescriptions due to high price tags, new research shows.
Dec 3, 2021
0
2
During a year when millions are working remotely, employers that provide health insurance for the bulk of working-age Americans bolstered access to telemedicine and mental-health services, a Kaiser Family Foundation survey ...
Nov 11, 2021
0
1
Health regulators on Tuesday unveiled their proposal to allow Americans to buy hearing aids without a prescription, a long-awaited move intended to make the devices more accessible to millions of people with hearing problems.
Oct 19, 2021
0
2
Care for the 15 most prevalent types of cancer in the U.S. cost approximately $156.2 billion in 2018, according to a team of Penn State College of Medicine researchers. The team also found that medication was the biggest ...
Oct 6, 2021
0
14
Lowering the age when older adults can enroll in Medicare might save them a lot of money, even if the age drops only a year or two from the current age of 65, a new study suggests.
Sep 13, 2021
0
24
Most older adults are not using tax-advantaged savings accounts to save for future health expenses, a new poll of people age 50 to 80 suggests, and those who do are more likely to have high incomes and education levels, and ...
Sep 9, 2021
0
1
The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people—especially ...
Aug 12, 2021
0
2
Among low-income, uninsured, or publicly insured women ages 25-64 years who were not up to date on cervical cancer screening, 72% perceived financial barriers to screening. The most commonly reported barriers were screening ...
Jun 29, 2021
0
0
Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for ...
Jun 15, 2021
0
4